Conjugated pneumococcal vaccine (Prevenar) ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 65 | Primary immunodeficiency | 1 |
65. Primary immunodeficiency
Clinical trials : 500 / Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00656409 (ClinicalTrials.gov) | June 2006 | 7/4/2008 | Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) | Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT) | Ataxia Telangiectasia (AT) | Drug: Conjugated pneumococcal vaccine (Prevenar) | Institute of Child Health | Great Ormond Street Hospital for Children NHS Foundation Trust | Completed | 2 Years | N/A | Both | 30 | Phase 3 | United Kingdom |